H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2

H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2 Suppliers list
Company Name: GL Biochem (Shanghai) Ltd  
Tel: 21-61263452 13641803416
Email: ymbetter@glbiochem.com
Company Name: Shanghai Hanhong Scientific Co.,Ltd.  
Tel: 021-54306202 13764082696
Email: info@hanhongsci.com
Company Name: Chemsky(shanghai)International Co.,Ltd.  
Tel: 021-50135380
Email: shchemsky@sina.com
Company Name: Cellmano Biotech Limited  
Tel: 0551-65326643 18156095617
Email: info@cellmano.com
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 17801761073 18101056239
Email: 3193328036@qq.com
H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2 Basic information
Product Name:H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2
Synonyms:YHKTDSFVGLM-NH2;(TYR0)-NEUROKININ A;TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2;H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2;TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2: YHKTDSFVGLM-NH2;L-Methioninamide, L-tyrosyl-L-histidyl-L-lysyl-L-threonyl-L-α-aspartyl-L-seryl-L-phenylalanyl-L-valylglycyl-L-leucyl- (9CI);Kassinin,1-de-L-aspartic acid-2-L-tyrosine-3-L-histidine-5-L-threonine-7-L-serine-
CAS:116868-93-0
MF:C59H89N15O16S
MW:1296.49
EINECS:
Product Categories:peptide
Mol File:Mol File
H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2 Structure
H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2 Chemical Properties
Boiling point 1739.9±65.0 °C(Predicted)
density 1.319±0.06 g/cm3(Predicted)
storage temp. -15°C
pka4.17±0.10(Predicted)
Safety Information
MSDS Information
H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2 Usage And Synthesis
UsesTyr0-Neurokinin A is a neuropeptide belongs to tachykinin peptide family. Tyr0-Neurokinin A is an agonist of Tacr2. Tyr0-Neurokinin A can be used in the research of insulin resistance, obesity, diabetes[1][2].
References[1] Gao X, et al. The study of the conformation and interaction of two tachykinin peptides in membrane mimicking systems by NMR spectroscopy and pulsed field gradient diffusion. Biopolymers. 1999 Oct 15;50(5):555-68. DOI:10.1002/(SICI)1097-0282(19991015)50:5<555::AID-BIP9>3.0.CO;2-X
[2] Gerhart-Hines Zachary, et al. Peptide agonists of Tacr2 for treatment of insulin resistance, diabetes and/or obesity. Patent. WO2021073742.
H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2 Preparation Products And Raw materials
Tag:H-TYR-HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2(116868-93-0) Related Product Information
(TYR0)-C-TYPE NATRIURETIC PEPTIDE (32-53) (HUMAN, PORCINE, RAT) (TYR0)-KALIURETIC PEPTIDE (HUMAN) (TYR0)-FIBRINOPEPTIDE A H-TYR-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-GLU-ILE-ARG-ALA-THR-SER-OH [TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN (TYR0)-HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT) (TYR0)-STRESSCOPIN-RELATED PEPTIDE (HUMAN) (TYR0)-UROCORTIN (RAT) (TYR0)-STRESSCOPIN (HUMAN) H-TYR-ASP-MET-HIS-ASP-PHE-PHE-VAL-GLY-LEU-MET-NH2